SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-014572
Filing Date
2021-04-27
Accepted
2021-04-27 16:32:17
Documents
6
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10023195x1_def14a.htm DEF 14A 1543796
2 nc10023195x1_pc01.jpg GRAPHIC 593193
3 nc10023195x1_pc02.jpg GRAPHIC 368190
4 nc10023195x1_piechart1.jpg GRAPHIC 205705
5 sig_pgraham.jpg GRAPHIC 14407
6 sig_rapple.jpg GRAPHIC 12332
  Complete submission text file 0001140361-21-014572.txt   3188140
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32302 | Film No.: 21859423
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences